GENOMIC HEALTH INC (GHDX) Fundamental Analysis & Valuation
NASDAQ:GHDX
63.44
-0.44 (-0.69%)
At close: Nov 7, 2019
63.44
0 (0%)
After Hours: 11/7/2019, 8:00:01 PM
This GHDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
No Fundamental Analysis report for GHDX not available.
GHDX Fundamentals: All Metrics, Ratios and Statistics
63.44
-0.44 (-0.69%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners93.16%
Inst Owner Change0%
Ins Owners1.23%
Ins Owner Change0%
Market Cap2.38B
Revenue(TTM)441.87M
Net Income(TTM)56.59M
Analysts60
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 36.88 | ||
| P/S | 5.4 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.5 |
EPS(TTM)1.43
EY2.25%
EPS(NY)1.72
Fwd EY2.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.76
BVpS9.29
TBVpSN/A
PEG (NY)0.88
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.29% | ||
| ROE | 16.2% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 12.56% | ||
| PM (TTM) | 12.81% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.96 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 14.43 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
EPS Next Y50.48%
EPS Next 2Y27.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.22%
Revenue growth 3YN/A
Revenue growth 5Y9.89%
Sales Q2Q%12.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
GENOMIC HEALTH INC / GHDX FAQ
Can you provide the ChartMill fundamental rating for GENOMIC HEALTH INC?
ChartMill assigns a fundamental rating of 5 / 10 to GHDX.
What is the valuation status of GENOMIC HEALTH INC (GHDX) stock?
ChartMill assigns a valuation rating of 0 / 10 to GENOMIC HEALTH INC (GHDX). This can be considered as Overvalued.
How profitable is GENOMIC HEALTH INC (GHDX) stock?
GENOMIC HEALTH INC (GHDX) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for GHDX stock?
The Price/Earnings (PE) ratio for GENOMIC HEALTH INC (GHDX) is 44.36 and the Price/Book (PB) ratio is 6.83.
What is the earnings growth outlook for GENOMIC HEALTH INC?
The Earnings per Share (EPS) of GENOMIC HEALTH INC (GHDX) is expected to grow by 50.48% in the next year.